On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
SCENESSE is approved to increase pain-free light exposure in adults with erythropoietic protoporphyria and a history of phototoxic reactions.
Pigmentation pathway
Afamelanotide acts predominantly at the melanocortin-1 receptor. This explains its pigmentation-related activity but does not turn every melanocortin compound into the same medicine. [1]
What the evidence shows
Early pigmentation research
Human pharmacokinetic research studied Melanotan I and changes in pigmentation. A pigmentation effect alone does not establish prevention of skin cancer or general safety for cosmetic tanning. [2]
Approved indication is narrow
The SCENESSE label concerns a controlled-release afamelanotide implant used for a rare photosensitivity disorder. That approval should not be applied to powders or sprays sold under a similar name. [1]
What remains unknown
Equivalence of other formulations and benefits for routine cosmetic tanning are not established by the approved implant label.
Safety
Skin changes and hypersensitivity
The label warns about serious hypersensitivity and darkening of existing pigmented lesions. It includes skin monitoring and continued sun/light protection; darker skin is not permission for unrestricted exposure. [1]
Approved implant has distinct handling
SCENESSE is a sterile, bioresorbable afamelanotide implant administered by a trained healthcare professional. The label requires refrigeration and light protection for that finished implant; these requirements are not a recipe for preparing a Melanotan powder. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Does Melanotan I being related to an approved medicine make every vial approved?
No. Approval applies to the specific product, formulation, manufacturing controls, and indication.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- SCENESSE prescribing informationDailyMed · Afamelanotide implant · May 2026
- Melanotan I pigmentation and pharmacokinetics1997 · Original research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.